EFFICACY AND SAFETY OF CILAZAPRIL IN HYPERTENSIVE PATIENTS WITH MODERATE TO SEVERE RENAL IMPAIRMENT

被引:0
|
作者
CARLSEN, JE [1 ]
HANSEN, FM [1 ]
JENSEN, HA [1 ]
机构
[1] HVIDOVRE UNIV HOSP,DEPT NEPHROL,DK-2650 HVIDOVRE,DENMARK
来源
AMERICAN JOURNAL OF MEDICINE | 1989年 / 87卷 / 6B期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S79 / S82
页数:4
相关论文
共 50 条
  • [1] EFFECT OF CILAZAPRIL IN HYPERTENSIVE PATIENTS WITH RENAL IMPAIRMENT
    SANCHEZ, RA
    TRABALLI, CA
    GILBERT, BH
    GIANNONE, CA
    LONG, G
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 (02) : 222 - 227
  • [2] Saxagliptin Efficacy and Safety in Patients with Moderate Renal Impairment
    Perl, Shira
    Cook, William
    Wei, Cheryl
    Iqbal, Nayyar
    Hirshberg, Boaz
    DIABETES, 2015, 64 : A330 - A330
  • [3] Efficacy and Safety of Gemigliptin in Type 2 Diabetes Patients with Moderate to Severe Renal Impairment
    Yoon, Sun Ae
    Han, Byoung Geun
    Kim, Sung Gyun
    Han, Sang Youb
    Jo, Young-Il
    Jeong, Kyung Hwan
    Oh, Kook-Hwan
    Park, Hyoungchun
    Park, Sun-Hee
    Kang, Shin-Wook
    Na, Ki-Ryang
    Kang, Sun Woo
    Kim, Nam-Ho
    Kim, Sung-Ho
    Jang, Younghwan
    Cha, Dae Ryong
    DIABETES, 2016, 65 : A314 - A315
  • [4] Efficacy and safety of gemigliptin in type 2 diabetes patients with moderate to severe renal impairment
    Yoon, Sun Ae
    Han, Byoung Geun
    Kim, Sung Gyun
    Han, Sang Youb
    Jo, Young-Il
    Jeong, Kyung Hwan
    OH, Kook-Hwan
    Park, Hyoungchun
    Park, Sun-Hee
    Kang, Shin-Wook
    Na, Ki-Ryang
    Kang, Sun Woo
    Kim, Nam-Ho
    Jang, YoungHwan
    Kim, Sung-Ho
    Cha, Dae Ryong
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S126 - S126
  • [5] Efficacy and safety of gemigliptin in type 2 diabetes patients with moderate to severe renal impairment
    Yoon, S.
    Han, B.
    Kim, S.
    Han, S.
    Jo, Y. -I.
    Jeong, K.
    Oh, K. -H.
    Park, H.
    Park, S. -H.
    Kang, S. -W.
    Na, K. -R.
    Jang, Y.
    Kim, S. -H.
    Cha, D.
    DIABETOLOGIA, 2015, 58 : S387 - S387
  • [7] Efficacy and safety of gemigliptin in type 2 diabetes patients with moderate to severe renal impairment (GUARD study)
    Yoon, S.
    Han, B.
    Kim, S.
    Han, S.
    Jo, Y-I.
    Jeong, K.
    Oh, K. -H.
    Park, H.
    Park, S. -H.
    Kang, S. -W.
    Na, K. -R.
    Jang, Y.
    Kim, S. -H.
    Cha, D.
    DIABETOLOGIA, 2016, 59 : S361 - S362
  • [8] Fluvastatin efficacy and safety profile in patients with moderate to severe renal impairment: results from the fluvastatin pooling analysis
    Holdaas, H.
    Wanner, C.
    Gimpelewicz, C.
    Abletshauser, C.
    Verpilleux, M. P.
    Logan, J. O.
    Bortolini, M.
    EUROPEAN HEART JOURNAL, 2005, 26 : 337 - 337
  • [9] Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection and Moderate to Severe Renal Impairment: An Integrated Analysis
    Lawitz, Eric J.
    Gane, Edward J.
    Zadeikis, Neddie
    Sise, Meghan
    Zamor, Philippe J.
    Persico, Marcell
    Yoshida, Eric M.
    Abunimeh, Manal
    Pugatch, David
    Yu, Yao
    Krishnan, Preethi
    Mensa, Federico J.
    Pol, Stanislas
    HEPATOLOGY, 2018, 68 : 426A - 426A
  • [10] Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment
    Perl, Shira
    Cook, William
    Wei, Cheryl
    Iqbal, Nayyar
    Hirshberg, Boaz
    DIABETES THERAPY, 2016, 7 (03) : 527 - 535